Table of Contents:
1 Report Prologue
2 Market Introduction
2.1 Introduction
2.2 Scope of Study
2.3 Research Objective
2.4 Assumptions & Limitations
2.4.1 Assumptions
2.4.2 Limitations
2.5 Market Structure
3 Research Methodology
3.1.1 Primary Research Methodology
3.1.2 Secondary Research Methodology
3.1.3 Market Share Analysis
3.1.4 Trade Analysis
3.2 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising prevalence of chronic disease (45%)
4.2.2 Growing awareness about biohacking (25%)
4.2.3 Increasing demand for innovative medical devices and sensors (30%)
4.3 Restraints
4.3.1 Lack of cyber security practices
4.4 Opportunities
4.4.1 Technological advancement
4.5 Mega Trends
4.5.1 Exploration of future biohacking products on rise
4.6 Macroeconomic indicators
5 Market Factor Analysis
5.1 Value Chain Analysis
5.1.1 Primary activities
5.1.2 Secondary activities
5.2 Porters Five Forces Model
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Buyers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitutes
5.2.5 Intensity of Rivalry
6 Global Biohacking Market, By Type
6.1 Introduction
6.2 Outside Biohacking
6.3 Inside Biohacking
7 Global Biohacking Market by Product
7.1 Introduction
7.2 Smart Drugs
7.3 Sensors
7.4 Strains
7.5 Others
8 Global Biohacking Market by Application
8.1 Introduction
8.2 Synthetic Biology
8.3 Genetic Engineering
8.4 Forensic science
8.5 Diagnosis & Treatment
8.6 Drug testing
8.7 Others
9 Global Biohacking Market, By End User
9.1 Introduction
9.2 Pharmaceutical & Biotechnology Companies
9.3 Forensic Laboratories
9.4 Others
10 Global Biohacking Market, By Region
10.1 Introduction
10.2 Americas
10.2.1 U.S.
10.2.2 Canada
10.2.3 South America
10.3 Europe
10.3.1 Germany
10.3.2 France
10.3.3 U.K
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Western Europe
10.3.7 Eastern Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Republic of Korea
10.4.6 Rest of Asia Pacific
10.5 Middle East & Africa
10.5.1 United Arab Emirates
10.5.2 Saudi Arabia
10.5.3 Oman
10.5.4 Kuwait
10.5.5 Qatar
10.5.6 Rest of Middle East & Africa
11 Company Landscape
11.1 Introduction: Key Players
11.2 Company Share Analysis
12 Company Profile
12.1 Fitbit, Inc.
12.1.1 Company Overview
12.1.2 Financials
12.1.3 Products
12.1.4 Strategy
12.1.5 Key Developments
12.2 Apple
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Products
12.2.4 Strategy
12.2.5 Key Developments
12.3 Synbiota
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Products
12.3.4 Strategy
12.3.5 Key Developments
12.4 THE ODIN
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Products
12.4.4 Strategy
12.4.5 Key Developments
12.5 HVMN, Inc.
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Products
12.5.4 Strategy
12.5.5 Key Developments
12.6 Thync Global Inc., U.S.A.
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Products
12.6.4 Strategy
12.6.5 Key Developments
12.7 MoodMetric
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Products
12.7.4 Strategy
12.7.5 Key Developments
13 Conclusion
13.1 Key Findings
13.1.1 CEO's Viewpoint
13.1.2 Unmet Needs
13.1.3 Key Companies to Watch
13.1.4 Prediction of Biohacking Industry
14 Appendix
14.1 Discussion Blue Print
14.2 References